Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair in Outpatients With COPD Acute Exacerbation
NCT00531791Phase 3Completed
- Sponsor
- Université Laval
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Started Nov 2007; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00531791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531791.